Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 373

1.

Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.

Fargion S, Stazi MA, Fracanzani AL, Mattioli M, Sampietro M, Tavazzi D, Bertelli C, Patriarca V, Mariani C, Fiorelli G.

Blood Cells Mol Dis. 2001 Mar-Apr;27(2):505-11.

PMID:
11500061
2.

Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.

Fracanzani AL, Fargion S, Stazi MA, Valenti L, Amoroso P, Cariani E, Sangiovanni A, Tommasini M, Rossini A, Bertelli C, Fatta E, Patriarca V, Brescianini S, Stroffolini T.

Blood Cells Mol Dis. 2005 Jul-Aug;35(1):27-32.

PMID:
15894495
3.

Mutations of the HFE gene and the risk of hepatocellular carcinoma.

Racchi O, Mangerini R, Rapezzi D, Gaetani GF, Nobile MT, Picciotto A, Ferraris AM.

Blood Cells Mol Dis. 1999 Oct-Dec;25(5-6):350-3.

PMID:
10660482
4.

HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma.

Lauret E, Rodríguez M, González S, Linares A, López-Vázquez A, Martínez-Borra J, Rodrigo L, López-Larrea C.

Am J Gastroenterol. 2002 Apr;97(4):1016-21.

PMID:
12003382
5.

Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver.

Blanc JF, De Ledinghen V, Bernard PH, de Verneuil H, Winnock M, Le Bail B, Carles J, Saric J, Balabaud C, Bioulac-Sage P.

J Hepatol. 2000 May;32(5):805-11.

PMID:
10845668
6.

Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.

Sikorska K, Romanowski T, Stalke P, Iżycka-Świeszewska E, Bielawski KP.

Hepatobiliary Pancreat Dis Int. 2011 Jun;10(3):270-5.

7.

HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence.

Hellerbrand C, Pöppl A, Hartmann A, Schölmerich J, Lock G.

Clin Gastroenterol Hepatol. 2003 Jul;1(4):279-84.

PMID:
15017669
8.

Mutation analysis of the HFE gene in German hemochromatosis patients and controls using automated SSCP-based capillary electrophoresis and a new PCR-ELISA technique.

Hellerbrand C, Bosserhoff AK, Seegers S, Lingner G, Wrede C, Lock G, Schölmerich J, Büttner R.

Scand J Gastroenterol. 2001 Nov;36(11):1211-6.

PMID:
11686223
9.

Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.

Bonkovsky HL, Jawaid Q, Tortorelli K, LeClair P, Cobb J, Lambrecht RW, Banner BF.

J Hepatol. 1999 Sep;31(3):421-9.

PMID:
10488699
10.

Incidence of liver disease in people with HFE mutations.

Willis G, Wimperis JZ, Lonsdale R, Fellows IW, Watson MA, Skipper LM, Jennings BA.

Gut. 2000 Mar;46(3):401-4.

11.

Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.

Nahon P, Sutton A, Rufat P, Ziol M, Thabut G, Schischmanoff PO, Vidaud D, Charnaux N, Couvert P, Ganne-Carrie N, Trinchet JC, Gattegno L, Beaugrand M.

Gastroenterology. 2008 Jan;134(1):102-10. Epub 2007 Oct 26.

PMID:
18061182
12.

[The H63D mutation in the HFE gene is related to the risk of hepatocellular carcinoma].

Ropero P, Briceño O, López-Alonso G, Agúndez JA, González Fernández FA, García-Hoz F, Villegas Martínez A, Díaz-Rubio M, Ladero JM.

Rev Esp Enferm Dig. 2007 Jul;99(7):376-81. Spanish.

13.

Mutations of the HFE gene in patients with hepatocellular carcinoma.

Cauza E, Peck-Radosavljevic M, Ulrich-Pur H, Datz C, Gschwantler M, Schöniger-Hekele M, Hackl F, Polli C, Rasoul-Rockenschaub S, Müller C, Wrba F, Gangl A, Ferenci P.

Am J Gastroenterol. 2003 Feb;98(2):442-7.

PMID:
12591066
14.

Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.

Piperno A, Vergani A, Malosio I, Parma L, Fossati L, Ricci A, Bovo G, Boari G, Mancia G.

Hepatology. 1998 Oct;28(4):1105-9.

PMID:
9755249
15.

C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan.

Shiono Y, Ikeda R, Hayashi H, Wakusawa S, Sanae F, Takikawa T, Imaizumi Y, Yano M, Yoshioka K, Kawanaka M, Yamada G.

Intern Med. 2001 Sep;40(9):852-6.

16.

HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.

Erhardt A, Maschner-Olberg A, Mellenthin C, Kappert G, Adams O, Donner A, Willers R, Niederau C, Häussinger D.

J Hepatol. 2003 Mar;38(3):335-42.

PMID:
12586300
17.

Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.

Geier A, Reugels M, Weiskirchen R, Wasmuth HE, Dietrich CG, Siewert E, Gartung C, Lorenzen J, Bosserhoff AK, Brügmann M, Gressner AM, Matern S, Lammert F.

Liver Int. 2004 Aug;24(4):285-94.

PMID:
15287851
18.

HFE mutations, iron deficiency and overload in 10,500 blood donors.

Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, Napier JA, Worwood M.

Br J Haematol. 2001 Aug;114(2):474-84.

PMID:
11529872
20.

Differential HFE allele expression in hemochromatosis heterozygotes.

Rosmorduc O, Poupon R, Nion I, Wendum D, Feder J, Béréziat G, Hermelin B.

Gastroenterology. 2000 Oct;119(4):1075-86.

PMID:
11040194
Items per page

Supplemental Content

Write to the Help Desk